T1	PROC 16 49	prevención de úlceras por presión
#1	AnnotatorNotes T1	C0150315; Pressure Ulcer Prevention; Therapeutic or Preventive Procedure
T2	DISO 30 49	úlceras por presión
#2	AnnotatorNotes T2	C0011127; Pressure Ulcer; Disease or Syndrome
T3	CHEM 54 69	aceite de oliva
#3	AnnotatorNotes T3	C0069449; olive oil; Organic Chemical · Food
T4	DISO 316 319	UPP
#4	AnnotatorNotes T4	C0011127; Pressure Ulcer; Disease or Syndrome
T5	CHEM 96 125	ácidos grasos hiperoxigenados
T6	PROC 156 182	estudio de no inferioridad
#5	AnnotatorNotes T6	C4505128; Non-Inferiority Trial; Research Activity
T7	PROC 199 218	Evaluar la eficacia
#6	AnnotatorNotes T7	C1707887; Efficacy Study; Research Activity
T8	PROC 225 242	aplicación tópica
#7	AnnotatorNotes T8	C0683174; topical application; Therapeutic or Preventive Procedure
T9	CHEM 246 261	aceite de oliva
#8	AnnotatorNotes T9	C0069449; olive oil; Organic Chemical · Food
T10	DISO 605 608	UPP
#9	AnnotatorNotes T10	C0011127; Pressure Ulcer; Disease or Syndrome
T11	PROC 281 314	prevención de úlceras por presión
#10	AnnotatorNotes T11	C0150315; Pressure Ulcer Prevention; Therapeutic or Preventive Procedure
T12	DISO 295 314	úlceras por presión
#11	AnnotatorNotes T12	C0011127; Pressure Ulcer; Disease or Syndrome
T13	CHEM 367 396	ácidos grasos hiperoxigenados
T14	PROC 441 476	Determinar la seguridad terapéutica
#12	AnnotatorNotes T14	C1705187; Safety Study; Research Activity
T15	DISO 478 494	efectos adversos
#13	AnnotatorNotes T15	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T16	PROC 502 519	aplicación tópica
#14	AnnotatorNotes T16	C0683174; topical application; Therapeutic or Preventive Procedure
T17	CHEM 523 538	aceite de oliva
#15	AnnotatorNotes T17	C0069449; olive oil; Organic Chemical · Food
T18	DISO 699 702	UPP
#16	AnnotatorNotes T18	C0011127; Pressure Ulcer; Disease or Syndrome
T19	CHEM 727 731	AGHO
T20	CHEM 636 664	preparado de aceite de oliva
T21	PROC 794 896	ensayo clínico de no inferioridad, multicéntrico, aleatorizado y controlado, con doble enmascaramiento
#17	AnnotatorNotes T21	C4505128; Non-Inferiority Trial; Research Activity + C1096776; Multicenter Study; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity
T22	DISO 1018 1021	UPP
#18	AnnotatorNotes T22	C0011127; Pressure Ulcer; Disease or Syndrome
T23	DISO 1105 1108	UPP
#19	AnnotatorNotes T23	C0011127; Pressure Ulcer; Disease or Syndrome
T24	DISO 1149 1178	situación de gravedad extrema
T25	DISO 1124 1143	enfermedad vascular
#20	AnnotatorNotes T25	C0042373; Vascular Diseases; Disease or Syndrome
T26	CHEM 1484 1488	AGHO
T27	PROC 1305 1317	intervención
#21	AnnotatorNotes T27	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T28	CHEM 1490 1498	Mepentol
#22	AnnotatorNotes T28	C1313804; Mepentol; Biologically Active Substance · Organic Chemical
T29	DISO 1552 1555	UPP
#23	AnnotatorNotes T29	C0011127; Pressure Ulcer; Disease or Syndrome
T30	CHEM 1385 1410	preparado de aceite oliva
T31	DISO 1834 1837	UPP
#24	AnnotatorNotes T31	C0011127; Pressure Ulcer; Disease or Syndrome
T32	CHEM 1953 1957	AGHO
T33	DISO 2382 2385	UPP
#25	AnnotatorNotes T33	C0011127; Pressure Ulcer; Disease or Syndrome
T34	PROC 1662 1687	análisis de supervivencia
#26	AnnotatorNotes T34	C0038953; Survival Analysis; Research Activity
T35	CHEM 2563 2567	AGHO
T36	CHEM 1854 1869	aceite de oliva
#27	AnnotatorNotes T36	C0069449; olive oil; Organic Chemical · Food
T37	DISO 2631 2634	UPP
#28	AnnotatorNotes T37	C0011127; Pressure Ulcer; Disease or Syndrome
T38	DISO 2174 2188	efecto adverso
#29	AnnotatorNotes T38	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T39	PROC 2301 2318	aplicación tópica
#30	AnnotatorNotes T39	C0683174; topical application; Therapeutic or Preventive Procedure
T40	CHEM 2323 2338	aceite de oliva
#31	AnnotatorNotes T40	C0069449; olive oil; Organic Chemical · Food
T41	CHEM 398 402	AGHO
T42	PROC 2357 2385	prevenir la aparición de UPP
#32	AnnotatorNotes T42	C0150315; Pressure Ulcer Prevention; Therapeutic or Preventive Procedure
T43	DISO 433 436	UPP
#33	AnnotatorNotes T43	C0011127; Pressure Ulcer; Disease or Syndrome
T44	CHEM 2496 2511	aceite de oliva
#34	AnnotatorNotes T44	C0069449; olive oil; Organic Chemical · Food
T45	PROC 2618 2634	prevenir las UPP
#35	AnnotatorNotes T45	C0150315; Pressure Ulcer Prevention; Therapeutic or Preventive Procedure
T46	PROC 715 722	tratado
#36	AnnotatorNotes T46	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T47	PROC 621 628	tratado
#37	AnnotatorNotes T47	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T48	ANAT 1135 1143	vascular
#38	AnnotatorNotes T48	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T50	Route 236 242	tópica
#39	AnnotatorNotes T50	C1522168; Topical Route of Drug Administration; Functional Concept
T51	LIVB 324 342	pacientes ancianos
#40	AnnotatorNotes T51	C0001792; Elderly (population group); Population Group
T53	Route 513 519	tópica
#41	AnnotatorNotes T53	C1522168; Topical Route of Drug Administration; Functional Concept
T58	Date 1028 1041	enero de 2011
T59	Date 1044 1057	abril de 2013
T60	Neg_cue 1059 1072	Se excluyeron
T61	LIVB 1220 1228	personas
#42	AnnotatorNotes T61	C0027361; Persons; Population Group
T62	Frequency 1344 1357	cada 12 horas
T63	LIVB 1438 1456	grupo experimental
#43	AnnotatorNotes T63	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T64	LIVB 1501 1514	grupo control
#44	AnnotatorNotes T64	C0009932; Control Groups; Group
T67	Neg_cue 2167 2173	ningún
T70	Route 2312 2318	tópica
#45	AnnotatorNotes T70	C1522168; Topical Route of Drug Administration; Functional Concept
T71	LIVB 2389 2424	pacientes de residencias de mayores
T76	LIVB 915 951	residentes de residencias de mayores
T77	LIVB 1073 1083	residentes
#46	AnnotatorNotes T77	C0376326; Institutionalized Persons; Patient or Disabled Group (?)
T78	LIVB 1746 1756	residentes
#47	AnnotatorNotes T78	C0376326; Institutionalized Persons; Patient or Disabled Group (?)
T79	LIVB 1893 1903	residentes
#48	AnnotatorNotes T79	C0376326; Institutionalized Persons; Patient or Disabled Group (?)
T80	LIVB 1926 1936	residentes
#49	AnnotatorNotes T80	C0376326; Institutionalized Persons; Patient or Disabled Group (?)
T81	LIVB 2656 2669	profesionales
#50	AnnotatorNotes T81	C0679924; professional occupation status; Professional or Occupational Group
T49	LIVB 2676 2684	usuarios
#51	AnnotatorNotes T49	C5236465; User (person); Human
T52	Spec_cue 992 998	riesgo
A1	Population_data T51 Age
A2	Assertion T77 Negated
A3	Assertion T38 Negated
A4	Population_data T76 Age
A5	Population_data T71 Age
A6	Assertion T22 Speculated
A7	Assertion T23 Negated
A8	Assertion T25 Negated
A9	Assertion T24 Negated
R1	Before Arg1:T1 Arg2:T2	
R2	Used_for Arg1:T3 Arg2:T1	
R3	Used_for Arg1:T5 Arg2:T1	
R4	Has_Route_or_Mode Arg1:T9 Arg2:T50	
R5	Used_for Arg1:T9 Arg2:T8	
R6	Before Arg1:T11 Arg2:T12	
R7	Before Arg1:T11 Arg2:T4	
R8	Used_for Arg1:T9 Arg2:T11	
R9	Experiences Arg1:T51 Arg2:T4	
R10	Experiences Arg1:T51 Arg2:T12	
R11	Experiences Arg1:T51 Arg2:T11	
R12	Experiences Arg1:T51 Arg2:T8	
R13	Experiences Arg1:T51 Arg2:T43	
R14	Before Arg1:T11 Arg2:T43	
R15	Used_for Arg1:T41 Arg2:T11	
R16	Used_for Arg1:T13 Arg2:T11	
R17	Experiences Arg1:T51 Arg2:T13	
R18	Experiences Arg1:T51 Arg2:T41	
R19	Causes Arg1:T17 Arg2:T15	
R20	Used_for Arg1:T17 Arg2:T16	
R21	Has_Route_or_Mode Arg1:T17 Arg2:T53	
R22	Used_for Arg1:T20 Arg2:T47	
T54	Neg_cue 665 667	no
T55	Quantifier_or_Qualifier 671 679	superior
A10	Assertion T55 Negated
R23	Negation Arg1:T54 Arg2:T55	
R24	Used_for Arg1:T19 Arg2:T46	
T56	CONC 750 775	margen de no inferioridad
R27	Speculation Arg1:T52 Arg2:T22	
T57	Quantifier_or_Qualifier 999 1014	moderado o alto
R28	After Arg1:T22 Arg2:T58	
R29	Before Arg1:T22 Arg2:T59	
R30	Experiences Arg1:T76 Arg2:T22	
R31	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T57	
R32	Negation Arg1:T60 Arg2:T77	
R33	Experiences Arg1:T77 Arg2:T23	
T65	CONC 1112 1118	inicio
#52	AnnotatorNotes T65	C0439659; Beginning; Temporal Concept
R34	Overlap Arg1:T23 Arg2:T65	
R35	Location_of Arg1:T48 Arg2:T25	
R36	Experiences Arg1:T77 Arg2:T25	
R37	Experiences Arg1:T77 Arg2:T24	
R38	Used_for Arg1:T30 Arg2:T27	
R39	Has_Frequency Arg1:T30 Arg2:T62	
R40	Experiences Arg1:T63 Arg2:T27	
R41	Experiences Arg1:T64 Arg2:T28	
R42	Experiences Arg1:T64 Arg2:T26	
T66	CONC 1809 1815	inicio
#53	AnnotatorNotes T66	C0439659; Beginning; Temporal Concept
R43	Experiences Arg1:T79 Arg2:T36	
R44	Experiences Arg1:T79 Arg2:T31	
R45	Experiences Arg1:T80 Arg2:T32	
R46	Experiences Arg1:T80 Arg2:T31	
T68	CONC 2078 2103	margen de no inferioridad
R47	Negation Arg1:T67 Arg2:T38	
R48	Has_Route_or_Mode Arg1:T40 Arg2:T70	
R49	Used_for Arg1:T40 Arg2:T39	
R50	Before Arg1:T42 Arg2:T33	
R52	Experiences Arg1:T71 Arg2:T33	
R53	Experiences Arg1:T71 Arg2:T39	
R54	Experiences Arg1:T71 Arg2:T42	
R55	Used_for Arg1:T44 Arg2:T45	
R56	Used_for Arg1:T35 Arg2:T45	
R57	Before Arg1:T45 Arg2:T37	
R58	Experiences Arg1:T49 Arg2:T45	
R59	Experiences Arg1:T49 Arg2:T37	
R60	Experiences Arg1:T49 Arg2:T35	
R61	Experiences Arg1:T49 Arg2:T44	
T73	CONC 170 182	inferioridad
A12	Assertion T73 Negated
T74	Neg_cue 167 169	no
R63	Negation Arg1:T74 Arg2:T73	
R51	Used_for Arg1:T40 Arg2:T42	
#54	AnnotatorNotes T55	C0332272; Better; Qualitative Concept
#55	AnnotatorNotes T57	C1998133; Moderate to high risk of; Qualitative Concept
R25	Negation Arg1:T60 Arg2:T23	
#56	AnnotatorNotes T20	C0069449; olive oil; Organic Chemical · Food (?)
#57	AnnotatorNotes T30	C0069449; olive oil; Organic Chemical · Food (?)
A11	Experiencer T51 Patient
A13	Experiencer T76 Patient
A14	Experiencer T77 Patient
A15	Experiencer T61 Patient
A16	Experiencer T63 Patient
A17	Experiencer T64 Patient
A18	Experiencer T78 Patient
A19	Experiencer T79 Patient
A20	Experiencer T80 Patient
A21	Experiencer T71 Patient
A22	Experiencer T81 Other
A23	Experiencer T49 Patient
